{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:07:57Z","timestamp":1788545277917,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271480"],"award-info":[{"award-number":["82271480"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471460"],"award-info":[{"award-number":["82471460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Jiangsu Province of China","award":["BK20230053"],"award-info":[{"award-number":["BK20230053"]}]},{"name":"the Natural Science Foundation of Jiangsu Province of China","award":["BK20231120"],"award-info":[{"award-number":["BK20231120"]}]},{"name":"the STI2030-Major Projects","award":["2022ZD0211800"],"award-info":[{"award-number":["2022ZD0211800"]}]},{"name":"Nanjing Medical Science and Technology Development Foundation","award":["ZKX22025"],"award-info":[{"award-number":["ZKX22025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01777-9","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T06:41:52Z","timestamp":1750488112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe\/PS1dE9 mice"],"prefix":"10.1186","volume":"17","author":[{"given":"Rui","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsha","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"1777_CR1","doi-asserted-by":"crossref","unstructured":"Li T-R, Han Y. China obotP-AAo. Insights on amyloid-related imaging abnormalities from the Pre-Alzheimer\u2019s disease alliance of China. AN. 2022;1(1).","DOI":"10.36922\/an.v1i1.2"},{"key":"1777_CR2","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u20133821.","DOI":"10.1002\/alz.13809"},{"issue":"1","key":"1777_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR Jr., Morris JC, Sperling R, Frolich L, et al. On the path to 2025: Understanding the alzheimer\u2019s disease continuum. Alzheimers Res Ther. 2017;9(1):60.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1777_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1021\/acschemneuro.5b00265","volume":"7","author":"I Horvath","year":"2016","unstructured":"Horvath I, Jia X, Johansson P, Wang C, Moskalenko R, Steinau A, et al. Pro-inflammatory S100A9 protein as a robust biomarker differentiating early stages of cognitive impairment in alzheimer\u2019s disease. ACS Chem Neurosci. 2016;7(1):34\u20139.","journal-title":"ACS Chem Neurosci"},{"key":"1777_CR5","doi-asserted-by":"publisher","first-page":"668852","DOI":"10.3389\/fnins.2021.668852","volume":"15","author":"C Contini","year":"2021","unstructured":"Contini C, Olianas A, Serrao S, Deriu C, Iavarone F, Boroumand M, et al. Top-Down proteomics of human saliva highlights Anti-inflammatory, antioxidant, and antimicrobial defense responses in alzheimer disease. Front Neurosci. 2021;15:668852.","journal-title":"Front Neurosci"},{"issue":"49","key":"1777_CR6","doi-asserted-by":"publisher","first-page":"17824","DOI":"10.1523\/JNEUROSCI.1504-12.2012","volume":"32","author":"MP Kummer","year":"2012","unstructured":"Kummer MP, Vogl T, Axt D, Griep A, Vieira-Saecker A, Jessen F, et al. Mrp14 deficiency ameliorates amyloid beta burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. J Neurosci. 2012;32(49):17824\u20139.","journal-title":"J Neurosci"},{"issue":"4","key":"1777_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-013-1208-4","volume":"127","author":"C Wang","year":"2014","unstructured":"Wang C, Klechikov AG, Gharibyan AL, Warmlander SK, Jarvet J, Zhao L, et al. The role of pro-inflammatory S100A9 in alzheimer\u2019s disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127(4):507\u201322.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1777_CR8","doi-asserted-by":"publisher","first-page":"e8840","DOI":"10.1371\/journal.pone.0008840","volume":"5","author":"TY Ha","year":"2010","unstructured":"Ha TY, Chang KA, Kim J, Kim HS, Kim S, Chong YH, et al. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS ONE. 2010;5(1):e8840.","journal-title":"PLoS ONE"},{"issue":"3","key":"1777_CR9","doi-asserted-by":"publisher","first-page":"e32953","DOI":"10.1371\/journal.pone.0032953","volume":"7","author":"C Zhang","year":"2012","unstructured":"Zhang C, Liu Y, Gilthorpe J, van der Maarel JR. MRP14 (S100A9) protein interacts with alzheimer beta-amyloid peptide and induces its fibrillization. PLoS ONE. 2012;7(3):e32953.","journal-title":"PLoS ONE"},{"issue":"6","key":"1777_CR10","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.4049\/jimmunol.1002956","volume":"186","author":"JC Simard","year":"2011","unstructured":"Simard JC, Simon MM, Tessier PA, Girard D. Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol. 2011;186(6):3622\u201331.","journal-title":"J Immunol"},{"issue":"3","key":"1777_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J, Wang A, Meng X, Yalkun G, Xu A, Gao Z, et al. Edaravone Dexborneol versus Edaravone alone for the treatment of acute ischemic stroke: A phase III, randomized, Double-Blind, comparative trial. Stroke. 2021;52(3):772\u201380.","journal-title":"Stroke"},{"issue":"4","key":"1777_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"key":"1777_CR13","unstructured":"Early Alzheimer\u2019s Disease.: Developing Drugs for Treatment [https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/alzheimers-disease-developing-drugs-treatment-guidance-industy"},{"issue":"16","key":"1777_CR14","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1422998112","volume":"112","author":"SS Jiao","year":"2015","unstructured":"Jiao SS, Yao XQ, Liu YH, Wang QH, Zeng F, Lu JJ, et al. Edaravone alleviates alzheimer\u2019s disease-type pathologies and cognitive deficits. Proc Natl Acad Sci U S A. 2015;112(16):5225\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1777_CR15","doi-asserted-by":"publisher","first-page":"370368","DOI":"10.1155\/2014\/370368","volume":"2014","author":"F He","year":"2014","unstructured":"He F, Cao YP, Che FY, Yang LH, Xiao SH, Liu J. Inhibitory effects of Edaravone in beta-amyloid-induced neurotoxicity in rats. Biomed Res Int. 2014;2014:370368.","journal-title":"Biomed Res Int"},{"issue":"5","key":"1777_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/fcp.12782","volume":"36","author":"L Xu","year":"2022","unstructured":"Xu L, Gao Y, Hu M, Dong Y, Xu J, Zhang J, et al. Edaravone Dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2\/HO-1 signaling pathway in mice. Fundam Clin Pharmacol. 2022;36(5):790\u2013800.","journal-title":"Fundam Clin Pharmacol"},{"key":"1777_CR17","doi-asserted-by":"publisher","first-page":"1342226","DOI":"10.3389\/fphar.2024.1342226","volume":"15","author":"K Zhu","year":"2024","unstructured":"Zhu K, Bi S, Zhu Z, Zhang W, Yang X, Li J, et al. Edaravone Dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1\/Nrf2 signaling pathway. Front Pharmacol. 2024;15:1342226.","journal-title":"Front Pharmacol"},{"key":"1777_CR18","doi-asserted-by":"publisher","first-page":"110006","DOI":"10.1016\/j.neuropharm.2024.110006","volume":"255","author":"J Wang","year":"2024","unstructured":"Wang J, Du L, Zhang T, Chu Y, Wang Y, Wang Y, et al. Edaravone Dexborneol ameliorates the cognitive deficits of APP\/PS1 mice by inhibiting TLR4\/MAPK signaling pathway via upregulating TREM2. Neuropharmacology. 2024;255:110006.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1777_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1096\/fj.201900394RRR","volume":"34","author":"MJ Zhang","year":"2020","unstructured":"Zhang MJ, Zhao QC, Xia MX, Chen J, Chen YT, Cao X, et al. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome. FASEB J. 2020;34(1):648\u201362.","journal-title":"FASEB J"},{"issue":"1","key":"1777_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ymthe.2020.09.006","volume":"29","author":"W Tao","year":"2021","unstructured":"Tao W, Yu L, Shu S, Liu Y, Zhuang Z, Xu S, et al. miR-204-3p\/Nox4 mediates memory deficits in a mouse model of alzheimer\u2019s disease. Mol Ther. 2021;29(1):396\u2013408.","journal-title":"Mol Ther"},{"issue":"8","key":"1777_CR21","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/glia.24369","volume":"71","author":"KA Rahman","year":"2023","unstructured":"Rahman KA, Orlando M, Boulos A, Andrzejak E, Schmitz D, Ziv NE, et al. Microglia actively remove NR1 autoantibody-bound NMDA receptors and associated post-synaptic proteins in neuron microglia co-cultures. Glia. 2023;71(8):1804\u201329.","journal-title":"Glia"},{"issue":"2","key":"1777_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41386-022-01435-w","volume":"48","author":"S Shu","year":"2023","unstructured":"Shu S, Xu SY, Ye L, Liu Y, Cao X, Jia JQ, et al. Prefrontal parvalbumin interneurons deficits mediate early emotional dysfunction in alzheimer\u2019s disease. Neuropsychopharmacology. 2023;48(2):391\u2013401.","journal-title":"Neuropsychopharmacology"},{"key":"1777_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.phrs.2018.12.024","volume":"141","author":"MR Zimmer","year":"2019","unstructured":"Zimmer MR, Schmitz AE, Dietrich MO. Activation of Agrp neurons modulates memory-related cognitive processes in mice. Pharmacol Res. 2019;141:303\u20139.","journal-title":"Pharmacol Res"},{"issue":"9","key":"1777_CR24","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41591-022-01926-9","volume":"28","author":"H Jung","year":"2022","unstructured":"Jung H, Lee SY, Lim S, Choi HR, Choi Y, Kim M, et al. Anti-inflammatory clearance of amyloid-beta by a chimeric Gas6 fusion protein. Nat Med. 2022;28(9):1802\u201312.","journal-title":"Nat Med"},{"issue":"1","key":"1777_CR25","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/s41467-021-22301-1","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding X, Wang J, Huang M, Chen Z, Liu J, Zhang Q, et al. Loss of microglial sirpalpha promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun. 2021;12(1):2030.","journal-title":"Nat Commun"},{"issue":"2","key":"1777_CR26","doi-asserted-by":"publisher","first-page":"eaau6328","DOI":"10.1126\/sciadv.aau6328","volume":"5","author":"RY Pan","year":"2019","unstructured":"Pan RY, Ma J, Kong XX, Wang XF, Li SS, Qi XL, et al. Sodium Rutin ameliorates alzheimer\u2019s disease-like pathology by enhancing microglial amyloid-beta clearance. Sci Adv. 2019;5(2):eaau6328.","journal-title":"Sci Adv"},{"issue":"6141","key":"1777_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341(6141):84\u20137.","journal-title":"Science"},{"key":"1777_CR28","doi-asserted-by":"publisher","first-page":"1147360","DOI":"10.3389\/fphar.2023.1147360","volume":"14","author":"Y Yu","year":"2023","unstructured":"Yu Y, Zhou M, Long X, Yin S, Hu G, Yang X, et al. Study on the mechanism of action of Colchicine in the treatment of coronary artery disease based on network Pharmacology and molecular Docking technology. Front Pharmacol. 2023;14:1147360.","journal-title":"Front Pharmacol"},{"issue":"W1","key":"1777_CR29","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, et al. PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 2021;49(W1):W530\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"1777_CR30","doi-asserted-by":"publisher","first-page":"107268","DOI":"10.1016\/j.isci.2023.107268","volume":"26","author":"SY Xu","year":"2023","unstructured":"Xu SY, Jia JQ, Sun M, Bao XY, Xia SN, Shu S, et al. QHRD106 ameliorates ischemic stroke injury as a long-acting tissue Kallikrein Preparation. iScience. 2023;26(7):107268.","journal-title":"iScience"},{"issue":"23","key":"1777_CR31","doi-asserted-by":"publisher","first-page":"26721","DOI":"10.1021\/acsami.1c04163","volume":"13","author":"H Chaudhary","year":"2021","unstructured":"Chaudhary H, Iashchishyn IA, Romanova NV, Rambaran MA, Musteikyte G, Smirnovas V, et al. Polyoxometalates as effective Nano-inhibitors of amyloid aggregation of Pro-inflammatory S100A9 protein involved in neurodegenerative diseases. ACS Appl Mater Interfaces. 2021;13(23):26721\u201334.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"1777_CR32","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1021\/acschemneuro.0c00828","volume":"12","author":"M Leri","year":"2021","unstructured":"Leri M, Chaudhary H, Iashchishyn IA, Pansieri J, Svedruzic ZM, Gomez Alcalde S, et al. Natural compound from Olive oil inhibits S100A9 amyloid formation and cytotoxicity: implications for preventing alzheimer\u2019s disease. ACS Chem Neurosci. 2021;12(11):1905\u201318.","journal-title":"ACS Chem Neurosci"},{"key":"1777_CR33","doi-asserted-by":"crossref","unstructured":"Batista AF, Khan KA, Papavergi MT, Lemere CA. The Importance of Complement-Mediated Immune Signaling in Alzheimer\u2019s Disease Pathogenesis. Int J Mol Sci 2024;25(2).","DOI":"10.3390\/ijms25020817"},{"key":"1777_CR34","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye XY, Xie Y, Xie T. Oxidative stress: the core pathogenesis and mechanism of alzheimer\u2019s disease. Ageing Res Rev. 2022;77:101619.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"1777_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jemt.10299","volume":"60","author":"W Nacken","year":"2003","unstructured":"Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9\/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech. 2003;60(6):569\u201380.","journal-title":"Microsc Res Tech"},{"issue":"8","key":"1777_CR36","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1038\/sj.jid.5700820","volume":"127","author":"M Benedyk","year":"2007","unstructured":"Benedyk M, Sopalla C, Nacken W, Bode G, Melkonyan H, Banfi B, et al. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J Invest Dermatol. 2007;127(8):2001\u201311.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"1777_CR37","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/MCB.23.7.2564-2576.2003","volume":"23","author":"JA Hobbs","year":"2003","unstructured":"Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, et al. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol. 2003;23(7):2564\u201376.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"1777_CR38","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/MCB.23.3.1034-1043.2003","volume":"23","author":"MP Manitz","year":"2003","unstructured":"Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol. 2003;23(3):1034\u201343.","journal-title":"Mol Cell Biol"},{"issue":"27","key":"1777_CR39","doi-asserted-by":"publisher","first-page":"22948","DOI":"10.1074\/jbc.M112.357772","volume":"287","author":"MJ Ryu","year":"2012","unstructured":"Ryu MJ, Liu Y, Zhong X, Du J, Peterson N, Kong G, et al. Oncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosis. J Biol Chem. 2012;287(27):22948\u201358.","journal-title":"J Biol Chem"},{"issue":"3","key":"1777_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.1008647","volume":"86","author":"JM Ehrchen","year":"2009","unstructured":"Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009;86(3):557\u201366.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1777_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.yexcr.2005.10.013","volume":"312","author":"A Hermani","year":"2006","unstructured":"Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res. 2006;312(2):184\u201397.","journal-title":"Exp Cell Res"},{"issue":"2 Pt B","key":"1777_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.molimm.2015.05.014","volume":"67","author":"H Gao","year":"2015","unstructured":"Gao H, Zhang X, Zheng Y, Peng L, Hou J, Meng H. S100A9-induced release of Interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells. Mol Immunol. 2015;67(2 Pt B):223\u201332.","journal-title":"Mol Immunol"},{"issue":"1","key":"1777_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s42003-024-05814-5","volume":"7","author":"X Xin","year":"2024","unstructured":"Xin X, Liu H, Zhang S, Li P, Zhao X, Zhang X, et al. S100A8\/A9 promotes endometrial fibrosis via regulating RAGE\/JAK2\/STAT3 signaling pathway. Commun Biol. 2024;7(1):116.","journal-title":"Commun Biol"},{"issue":"2","key":"1777_CR44","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yexcr.2015.04.008","volume":"334","author":"R Wu","year":"2015","unstructured":"Wu R, Duan L, Cui F, Cao J, Xiang Y, Tang Y, et al. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1\/2 and p38 MAPK pathways. Exp Cell Res. 2015;334(2):228\u201338.","journal-title":"Exp Cell Res"},{"issue":"12","key":"1777_CR45","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1136\/annrheumdis-2014-206517","volume":"74","author":"RF Schelbergen","year":"2015","unstructured":"Schelbergen RF, Geven EJ, van den Bosch MH, Eriksson H, Leanderson T, Vogl T, et al. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis. Ann Rheum Dis. 2015;74(12):2254\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1777_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fimmu.2018.00447","volume":"9","author":"V Schenten","year":"2018","unstructured":"Schenten V, Plancon S, Jung N, Hann J, Bueb JL, Brechard S, et al. Secretion of the phosphorylated form of S100A9 from neutrophils is essential for the Proinflammatory functions of extracellular S100A8\/A9. Front Immunol. 2018;9:447.","journal-title":"Front Immunol"},{"key":"1777_CR47","doi-asserted-by":"crossref","unstructured":"Jung N, Schenten V, Bueb JL, Tolle F, Brechard S. MiRNAs regulate cytokine secretion induced by phosphorylated S100A8\/A9 in neutrophils. Int J Mol Sci 2019;20(22).","DOI":"10.3390\/ijms20225699"},{"issue":"1","key":"1777_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-021-00467-y","volume":"16","author":"E McDade","year":"2021","unstructured":"McDade E, Llibre-Guerra JJ, Holtzman DM, Morris JC, Bateman RJ. The informed road map to prevention of alzheimer disease: A call to arms. Mol Neurodegener. 2021;16(1):49.","journal-title":"Mol Neurodegener"},{"issue":"20","key":"1777_CR49","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: from immunotherapy to Immunoprevention. Cell. 2023;186(20):4260\u201370.","journal-title":"Cell"},{"issue":"4","key":"1777_CR50","first-page":"2437","volume":"18","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang Y, Zhang G, Lin Z, Du S. Protective effect of Edaravone on blood-brain barrier by affecting NRF-2\/HO-1 signaling pathway. Exp Ther Med. 2019;18(4):2437\u201342.","journal-title":"Exp Ther Med"},{"issue":"10","key":"1777_CR51","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1089\/neu.2011.1939","volume":"28","author":"GH Wang","year":"2011","unstructured":"Wang GH, Jiang ZL, Li YC, Li X, Shi H, Gao YQ, et al. Free-radical scavenger Edaravone treatment confers neuroprotection against traumatic brain injury in rats. J Neurotrauma. 2011;28(10):2123\u201334.","journal-title":"J Neurotrauma"},{"issue":"2","key":"1777_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/jpp\/rgab167","volume":"74","author":"Q Xie","year":"2022","unstructured":"Xie Q, Li J, Dong T, Yuan J, Lu D, Ma R, et al. Neuroprotective effects of synthetic Borneol and natural Borneol based on the neurovascular unit against cerebral ischaemic injury. J Pharm Pharmacol. 2022;74(2):236\u201349.","journal-title":"J Pharm Pharmacol"},{"key":"1777_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuroscience.2010.11.029","volume":"176","author":"R Liu","year":"2011","unstructured":"Liu R, Zhang L, Lan X, Li L, Zhang TT, Sun JH, et al. Protection by Borneol on cortical neurons against oxygen-glucose deprivation\/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor KappaappaB signaling pathway. Neuroscience. 2011;176:408\u201319.","journal-title":"Neuroscience"},{"issue":"4","key":"1777_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1208\/s12249-021-01999-8","volume":"22","author":"M Kulkarni","year":"2021","unstructured":"Kulkarni M, Sawant N, Kolapkar A, Huprikar A, Desai N. Borneol: a promising monoterpenoid in enhancing drug delivery across various physiological barriers. AAPS PharmSciTech. 2021;22(4):145.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1777_CR55","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/10717544.2017.1346002","volume":"24","author":"QL Zhang","year":"2017","unstructured":"Zhang QL, Fu BM, Zhang ZJ. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability. Drug Deliv. 2017;24(1):1037\u201344.","journal-title":"Drug Deliv"},{"issue":"4","key":"1777_CR56","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380.","journal-title":"Ann Neurol"},{"key":"1777_CR57","doi-asserted-by":"crossref","unstructured":"Afsar A, Chacon Castro MDC, Soladogun AS, Zhang L. Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer\u2019s Disease. Int J Mol Sci 2023;24(8).","DOI":"10.3390\/ijms24087258"},{"key":"1777_CR58","doi-asserted-by":"publisher","first-page":"102192","DOI":"10.1016\/j.arr.2024.102192","volume":"94","author":"X Guo","year":"2024","unstructured":"Guo X, Yan L, Zhang D, Zhao Y. Passive immunotherapy for alzheimer\u2019s disease. Ageing Res Rev. 2024;94:102192.","journal-title":"Ageing Res Rev"},{"issue":"6012","key":"1777_CR59","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in alzheimer\u2019s disease. Science. 2010;330(6012):1774.","journal-title":"Science"},{"key":"1777_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbi.2015.03.006","volume":"48","author":"AA Babcock","year":"2015","unstructured":"Babcock AA, Ilkjaer L, Clausen BH, Villadsen B, Dissing-Olesen L, Bendixen AT, et al. Cytokine-producing microglia have an altered beta-amyloid load in aged APP\/PS1 Tg mice. Brain Behav Immun. 2015;48:86\u2013101.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"1777_CR61","doi-asserted-by":"publisher","first-page":"e88924","DOI":"10.1371\/journal.pone.0088924","volume":"9","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Chang KA, Ha TY, Kim J, Ha S, Shin KY, et al. S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS ONE. 2014;9(2):e88924.","journal-title":"PLoS ONE"},{"key":"1777_CR62","doi-asserted-by":"crossref","unstructured":"Gruel R, Bijnens B, Van Den Daele J, Thys S, Willems R, Wuyts D et al. S100A8-enriched microglia populate the brain of tau-seeded and accelerated aging mice. Aging Cell 2024:e14120.","DOI":"10.1101\/2023.11.10.566543"},{"issue":"10","key":"1777_CR63","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1182\/bloodadvances.2018016667","volume":"2","author":"M Pelletier","year":"2018","unstructured":"Pelletier M, Simard JC, Girard D, Tessier PA. Quinoline-3-carboxamides such as Tasquinimod are not specific inhibitors of S100A9. Blood Adv. 2018;2(10):1170\u20131.","journal-title":"Blood Adv"},{"key":"1777_CR64","doi-asserted-by":"crossref","unstructured":"Miura S, Iwamoto H, Namba M, Yamaguchi K, Sakamoto S, Horimasu Y et al. High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2024;11(1).","DOI":"10.1136\/bmjresp-2023-001803"},{"issue":"1","key":"1777_CR65","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12974-021-02317-6","volume":"18","author":"S Talley","year":"2021","unstructured":"Talley S, Valiauga R, Anderson L, Cannon AR, Choudhry MA, Campbell EM. DSS-induced inflammation in the colon drives a Proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod. J Neuroinflammation. 2021;18(1):263.","journal-title":"J Neuroinflammation"},{"key":"1777_CR66","doi-asserted-by":"crossref","unstructured":"Fan R, Satilmis H, Vandewalle N, Verheye E, Vlummens P, Maes A et al. Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma. J Immunother Cancer. 2023;11(1).","DOI":"10.1136\/jitc-2022-005319"},{"issue":"3","key":"1777_CR67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41401-023-01188-2","volume":"45","author":"E Cho","year":"2024","unstructured":"Cho E, Mun SJ, Kim HK, Ham YS, Gil WJ, Yang CS. Colon-targeted S100A8\/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models. Acta Pharmacol Sin. 2024;45(3):581\u201393.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"1777_CR68","doi-asserted-by":"publisher","first-page":"e5562","DOI":"10.1371\/journal.pone.0005562","volume":"4","author":"K Yanamandra","year":"2009","unstructured":"Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, Brorsson AC, et al. Amyloid formation by the pro-inflammatory S100A8\/A9 proteins in the ageing prostate. PLoS ONE. 2009;4(5):e5562.","journal-title":"PLoS ONE"},{"issue":"8","key":"1777_CR69","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1080\/07391102.2019.1632225","volume":"38","author":"F Liu","year":"2020","unstructured":"Liu F, Ma Z, Sang J, Lu F. Edaravone inhibits the conformational transition of amyloid-beta42: insights from molecular dynamics simulations. J Biomol Struct Dyn. 2020;38(8):2377\u201388.","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"1777_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13578-024-01230-8","volume":"14","author":"C Xu","year":"2024","unstructured":"Xu C, Mei Y, Yang R, Luo Q, Zhang J, Kou X, et al. Edaravone Dexborneol mitigates pathology in animal and cell culture models of alzheimer\u2019s disease by inhibiting neuroinflammation and neuronal necroptosis. Cell Biosci. 2024;14(1):55.","journal-title":"Cell Biosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01777-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:27Z","timestamp":1750532547000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01777-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01777-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Review Committee of Nanjing Drum Tower Hospital (No. 2024AE01014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}